HU911116D0 - Process for the production of lhrh analogues - Google Patents

Process for the production of lhrh analogues

Info

Publication number
HU911116D0
HU911116D0 HU911116A HU111691A HU911116D0 HU 911116 D0 HU911116 D0 HU 911116D0 HU 911116 A HU911116 A HU 911116A HU 111691 A HU111691 A HU 111691A HU 911116 D0 HU911116 D0 HU 911116D0
Authority
HU
Hungary
Prior art keywords
moiety
methotrexoyl
trp
arg
group
Prior art date
Application number
HU911116A
Other languages
English (en)
Other versions
HUT57235A (en
HU208159B (en
Inventor
Andrew V Schally
Tamas Janaky
Attila Juhasz
Sandor Bajusz
Original Assignee
Schally Andrew Victor
Tamas Janaky
Attila Juhasz
Sandor Bajusz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schally Andrew Victor, Tamas Janaky, Attila Juhasz, Sandor Bajusz filed Critical Schally Andrew Victor
Publication of HU911116D0 publication Critical patent/HU911116D0/hu
Publication of HUT57235A publication Critical patent/HUT57235A/hu
Publication of HU208159B publication Critical patent/HU208159B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Luminescent Compositions (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
HU911116A 1990-04-06 1991-04-05 Process for producing 1h-rh analogs and pharmaceutical compositions comprising same HU208159B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50551790A 1990-04-06 1990-04-06

Publications (3)

Publication Number Publication Date
HU911116D0 true HU911116D0 (en) 1991-10-28
HUT57235A HUT57235A (en) 1991-11-28
HU208159B HU208159B (en) 1993-08-30

Family

ID=24010633

Family Applications (1)

Application Number Title Priority Date Filing Date
HU911116A HU208159B (en) 1990-04-06 1991-04-05 Process for producing 1h-rh analogs and pharmaceutical compositions comprising same

Country Status (17)

Country Link
EP (1) EP0450461B1 (hu)
JP (1) JPH04224600A (hu)
KR (1) KR940701270A (hu)
AT (1) ATE127476T1 (hu)
AU (1) AU638319B2 (hu)
CA (1) CA2039908A1 (hu)
DE (1) DE69112684T2 (hu)
DK (1) DK0450461T3 (hu)
ES (1) ES2076393T3 (hu)
HR (1) HRP921273A2 (hu)
HU (1) HU208159B (hu)
IE (1) IE63278B1 (hu)
MC (1) MC2265A1 (hu)
NZ (1) NZ237705A (hu)
WO (1) WO1992022322A1 (hu)
YU (1) YU61991A (hu)
ZA (1) ZA914552B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6419655B1 (en) 1998-07-16 2002-07-16 Gonex, Inc. Method for controlling animal populations utilizing a sterilant projectile
US6326467B1 (en) 1989-02-23 2001-12-04 Colorado State University Research Foundation Hormone-recombinant toxin compounds and methods for using same
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
US5413990A (en) * 1993-08-06 1995-05-09 Tap Pharmaceuticals Inc. N-terminus modified analogs of LHRH
DE4338015A1 (de) * 1993-11-08 1995-05-11 Asta Medica Ag Verwendung von D-glucopyranuronsäuren und deren Derivaten zum Einbau in pharmakologisch wirksame Peptide und deren Salze
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor
US5753206A (en) * 1995-06-07 1998-05-19 Immunomedics, Inc. Radiometal-binding analogues of luteinizing hormone releasing hormone
US5843903A (en) * 1995-11-27 1998-12-01 The Administrators Of The Tulane Educational Fund Targeted cytotoxic anthracycline analogs
WO2004093807A2 (en) 2003-04-22 2004-11-04 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatin vectors
EP2719392B1 (en) 2008-06-12 2019-07-24 Ipsen Bioinnovation Limited Fusion proteins for use in the treatment of acromegaly
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
KR101346262B1 (ko) * 2013-06-19 2014-01-03 엘아이지넥스원 주식회사 다단 분리형 수중 운동체 및 이의 동작 방법
KR101355886B1 (ko) * 2013-11-19 2014-01-27 엘아이지넥스원 주식회사 다단 분리형 수중 운동체 및 이의 동작 방법
WO2019030284A1 (en) * 2017-08-09 2019-02-14 Helmholtz-Zentrum für Infektionsforschung GmbH NOVEL TARGETED CYTOTOXIC RATJADONE DERIVATIVES AND CONJUGATES THEREOF

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4263279A (en) * 1975-08-19 1981-04-21 Yeda Research & Development Co. Ltd Pharmaceutically active compositions containing adriamycin and daunomycin
US4894443A (en) * 1984-02-08 1990-01-16 Cetus Corporation Toxin conjugates
US4677193A (en) * 1985-02-22 1987-06-30 The Salk Institute For Biological Studies Peptides containing an aliphatic-aromatic ketone side chain
CA1275922C (en) * 1985-11-28 1990-11-06 Harunobu Amagase Treatment of cancer
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds
WO1990009799A1 (en) * 1989-02-23 1990-09-07 Colorado State University Research Foundation GnRH ANALOGS FOR DESTROYING GONADOTROPHS
BR9913040A (pt) * 1998-08-17 2001-05-08 Thermo Black Clawson Inc Processos de extrair um licor rico em açúcar e um componente de açúcar a partir de cana-de-açúcar

Also Published As

Publication number Publication date
HUT57235A (en) 1991-11-28
WO1992022322A1 (en) 1992-12-23
EP0450461A3 (en) 1992-03-11
DE69112684D1 (de) 1995-10-12
HU208159B (en) 1993-08-30
CA2039908A1 (en) 1991-10-07
EP0450461B1 (en) 1995-09-06
ZA914552B (en) 1992-06-24
IE63278B1 (en) 1995-04-05
JPH04224600A (ja) 1992-08-13
DE69112684T2 (de) 1996-02-01
IE911134A1 (en) 1991-10-09
ATE127476T1 (de) 1995-09-15
YU61991A (sh) 1994-04-05
MC2265A1 (fr) 1993-04-26
KR940701270A (ko) 1994-05-28
AU7410691A (en) 1991-10-10
AU638319B2 (en) 1993-06-24
ES2076393T3 (es) 1995-11-01
HRP921273A2 (en) 1998-06-30
DK0450461T3 (da) 1995-10-23
EP0450461A2 (en) 1991-10-09
NZ237705A (en) 1992-11-25

Similar Documents

Publication Publication Date Title
HU911116D0 (en) Process for the production of lhrh analogues
JPS6434997A (en) Peptide, manufacture, lhrh antagonistic medicine and manufacture
PT77067B (en) Method for making a peptide or a non-toxic salt thereof
GB2207433B (en) Acyclic cyclosporins
EP0190946B1 (en) Novel cyclic hexapeptide lhrh antagonists
DE3162788D1 (en) Nonapeptide and decapeptide agonists of luteinizing hormone releasing hormone containing heterocyclic amino acid residues, methods for their preparation, pharmaceutical compounds containing them, and their pharmaceutical use
KR860009041A (ko) GnRH길항제 IX의 제조방법
KR850000476B1 (ko) 펩티드의 제조방법
DE3265349D1 (en) Gnrh antagonists
MC2266A1 (fr) Analogues de la somatostatine
CA1238314A (en) Process for preparing basic heptapeptide vasopressin antagonists
NO934541L (no) LHRH analoger
EP0364819A3 (en) Lhrh analogs
IE832664L (en) Penems.

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: THE ADMINISTRATORS OF THE TULANE EDUCATION FOUND,

HMM4 Cancellation of final prot. due to non-payment of fee